US healthcare lobbyists outspend other pressure groups
BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7443.786-c (Published 01 April 2004) Cite this as: BMJ 2004;328:786
- Janice Hopkins Tanne
- New York
Healthcare lobbyists spent $237m (£130m; £195m), more than any other industry, to influence US senators and representatives, the White House, and federal agencies in 2000, says an article in the American Journal of Medicine (2004;116:474-7).
Drug companies and medical supply companies together spent $96m. Physicians and other health professionals, such as nurses, spent $46m, hospitals and nursing homes $40m, health insurance and managed care companies $31m, and disease advocacy and public health organisations spent $12m. During the study period, 1997-2000, spending on lobbying by health professionals grew by only 10% compared with 26% by other organisations.
An editorial in the same …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.